As the debate over how to lower US drug prices continues, the Inflation Reduction Act (IRA) drug price-setting provisions ...

The Russian government will create a temporary list of innovative drugs – the drugs, that will be a subject of state ...

US–Dutch–Chinese biotech Harbour BioMed (HKEX: 02142) has extended its partnership with British pharma major AstraZeneca (LSE ...

The Russian drugmaker Akselpharm has successfully defended its patent for osimertinib the active ingredient of UK pharma ...

US biotech major Biogen and privately-held Dayra Therapeutics have announced a research collaboration to discover and develop ...

Privately-held Italian drugmaker Angelini Pharma has breached the Code of Practice for the Association of the British ...

Switzerland is becoming the benchmark for American drug prices, warns the trade body Interpharma. A new US model links ...

The Danish government’s push to let citizens buy medicines from countries outside the EU is drawing sharp criticism from Lif, ...

US pharma major Johnson & Johnson (NYSE: JNJ) has halted its Phase IIb AuTonomy study after posdinemab failed to achieve a ...

Germany’s STADA Arzneimittel has received marketing authorizations from the European Commission (EC) for its Kefdensis and ...

Shares Danish pharma major Novo Nordisk were down 9.5% at 275.80 kroner today, after it announced disappointing top-line ...

The US Food and Drug Administration (FDA) has approved Padcev (enfortumab vedotin-ejfv), a nectin-4 directed antibody-drug ...